Trials / Conditions / Spinocerebellar Ataxia Type 3

Spinocerebellar Ataxia Type 3

20 registered clinical trials studyying Spinocerebellar Ataxia Type 3 — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia NCT03378414	Sclnow Biotechnology Co., Ltd.	Phase 2
Recruiting	A Safety and Pharmacokinetics Trial of VO659 in SCA1, SCA3 and HD NCT05822908	Vico Therapeutics B. V.	Phase 1 / Phase 2
Active Not Recruiting	Priming Motor Learning Through Exercise in People With Spinocerebellar Ataxia NCT05826171	Teachers College, Columbia University	N/A
Completed	Treatment of Transcranial Alternating Current Stimulation（tACS）on Cerebellar Ataxia NCT05557786	First Affiliated Hospital of Fujian Medical University	N/A
Terminated	STRIDES - a Clinical Research Study of an Investigational New Drug to Treat Spinocerebellar Ataxia NCT05490563	Seelos Therapeutics, Inc.	Phase 2 / Phase 3
Terminated	A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3 NCT05160558	Biogen	Phase 1
Withdrawn	Study of CAD-1883 for Spinocerebellar Ataxia NCT04301284	Cadent Therapeutics	Phase 2
Unknown	Efficacy Of Oral Trehalose In Spinocerebellar Ataxia 3 NCT04399265	National University of Malaysia	N/A
Unknown	Neuropsychiatry and Cognition in SCA3/MJD NCT04714307	Hospital de Clinicas de Porto Alegre	—
Completed	Instrumented Data Exchange for Ataxia Study NCT04268147	University of Chicago	—
Active Not Recruiting	Troriluzole in Adult Participants With Spinocerebellar Ataxia NCT03701399	Biohaven Pharmaceuticals, Inc.	Phase 3
Completed	Identification of Biomarkers in Spinocerebellar Ataxia 3 NCT03885167	University of Michigan	—
Completed	Repetitive Transcranial Magnetic Stimulation in SCA3 Patients NCT05502432	Ning Wang, MD., PhD.	N/A
Unknown	Natural History of Oculomotor Neurophysiology in Ataxic and Pre-ataxic Carriers of SCA3/MJD NCT04229823	Hospital de Clinicas de Porto Alegre	—
Unknown	Astrocytic Markers and the Pre-ataxic Period of SCA3/MJD - BIGPRO Study Astrocytes NCT04419974	Hospital de Clinicas de Porto Alegre	—
Completed	Safety and Efficacy of Lithium Carbonate in Patients With Spinocerebellar Ataxia Type 3 NCT01096082	Hospital de Clinicas de Porto Alegre	Phase 2 / Phase 3
Recruiting	Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford NCT01793168	Sanford Health	—
Withdrawn	Pilot Study of Safety and Efficacy of Sodium Phenylbutyrate in Spinocerebellar Ataxia Type 3 NCT01096095	Hospital de Clinicas de Porto Alegre	Phase 2
Unknown	Natural History Study of and Genetic Modifiers in Spinocerebellar Ataxias NCT01060371	University of Florida	—
Completed	Study to Determine the Safety and Tolerability of Varenicline (Chantix®) in Treating Spinocerebellar Ataxia Ty NCT00992771	University of South Florida	Phase 2